文献速递瘢痕与激光

白细胞介素10在瘢痕疙瘩治疗中的作用:文献综述

The Role of Interleukin 10 in Keloid Therapy: A Literature Review.
PubMed 文献 · Ann Plast Surg · 2021-11-01

本文综述瘢痕疙瘩与白细胞介素10(IL-10)的相关研究,检索PubMed、ScienceDirect、PLOS和Clinical Key等数据库,以interleukin 10、keloid和wound healing为医学主题词。多种动物模型显示,通过IL-10过表达可促进再生性愈合,机制包括减轻炎症性创面微环境、下调转化生长因子β/SMAD信号通路、增加细胞外基质分解及调节细胞外基质。作者认为IL-10因其多效性有潜力成为更具靶向性和前景的瘢痕疙瘩疗法。

要点

  • 瘢痕疙瘩是皮肤损伤后的病理性创面愈合反应,治疗对医生仍具挑战性。
  • IL-10是一种强效抗炎细胞因子,在胎儿无瘢痕再生性愈合中起重要作用。
  • 多种动物模型显示IL-10过表达可促进再生性愈合,并已推动人重组IL-10临床试验的开展。

核心结论

  • IL-10因其多效性有潜力成为更具靶向性和前景的瘢痕疙瘩疗法。

研究设计与样本

  • 文献综述,检索PubMed、ScienceDirect、PLOS和Clinical Key,以interleukin 10、keloid和wound healing为医学主题词。

主要发现

  • 瘢痕疙瘩与胎儿无瘢痕愈合代表组织修复谱的两个相反末端。
  • 多种动物模型显示,IL-10过表达通过减轻炎症性创面微环境、下调转化生长因子β/SMAD信号通路、增加细胞外基质分解和调节细胞外基质,成功促进再生性愈合。
  • 上述结果已推动研究人重组IL-10的临床试验开展。

临床怎么用

  • 原文未据此给出推荐,作者认为IL-10有潜力成为更具靶向性和前景的瘢痕疙瘩疗法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Keloids are pathological wound healing responses to dermal injuries. These scars may lead to considerable morbidity, but treatments remain challenging for physicians. Interleukin 10 (IL-10), a potent anti-inflammatory cytokine, plays a prominent role in fetal scarless regenerative healing; therefore, it may become a more targeted and effective therapy for keloids. This review aimed to obtain an overview of the background of keloid and IL-10 functions as its promising forthcoming treatment. MATERIALS AND METHODS: Studies were sought from Pubmed, ScienceDirect, PLOS, and Clinical Key. Keywords are interleukin 10, keloid, and wound healing as Medical Subject Headings terms. RESULTS AND DISCUSSION: Keloids and fetal scarless healing represent 2 opposing ends of the tissue repair spectrum. Promising multiple animal models have demonstrated successful regenerative healing promotion through IL-10 overexpression by its ability to minimize inflammatory wound microenvironment, downregulate transforming growth factor β/SMAD signaling pathway, increase extracellular matrix breakdown, and regulate extracellular matrix. These results have led to the development of clinical trials investigating human recombinant IL-10. CONCLUSIONS: Interleukin 10 has the potential to become a more targeted and promising therapy of keloids owing to its pleiotropic effects.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Harsono AD, Prasetyono TOH, Dilogo IH, et al. The Role of Interleukin 10 in Keloid Therapy: A Literature Review. Ann Plast Surg. 2021. PMID: 34724442. doi:10.1097/SAP.0000000000003044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。